Pub Date : 2025-10-01DOI: 10.1016/j.wjam.2025.09.004
Gao-feng LIU (刘高峰) , Xiao-li HUANG (黄小力) , Wei-xing ZHONG (钟伟兴) , Yin XIE (解寅) , Si-yuan XIE (谢思远) , Yuan-xun LIN (林源洵) , Yun-ao-long ZHANG (张沄奡龙) , Hong-wen LIU (刘洪文) , Qing-guang QIN (秦庆广) , Yi-kai LI (李义凯)
Objectives
This study aims to evaluate the current state of acupuncture randomized controlled trials (RCTs), their impact on guidelines, and future development trends, providing a reference for future research directions.
Methods
Search for acupuncture-related RCT articles in the Web of Science Core Collection and confirm their guideline inclusion on Google Scholar. Analyze study characteristics to predict future research directions.
Results
The analysis covered 1422 articles, reflecting a substantial rise in publications from 77 articles between 1993 and 2002 to 960 articles between 2013 and 2022. The Western Pacific region led in publication numbers with 622 articles (43.7 %), followed by Europe (466 articles; 32.8 %), Americas (250 articles; 17.6 %), Eastern Mediterranean (62 articles; 4.4 %), and Southeast Asia (22 articles; 1.5 %), with Africa showing a research void. Regrettably, only 29.6 % (421 articles) were incorporated into guidelines. The low rate of inclusion of research results in guidelines and the uneven distribution of research fields are particularly prominent. From 1993 to 2002, there were 77 articles, among which 51 (66.2 %) were included in the guidelines; from 2003 to 2012, there were 385 articles, with 202 (52.5 %) included; from 2013 to 2022, there were 960 articles, and only 168 (17.5 %) were included, showing a decreasing trend in the inclusion rate year by year. Regarding geographical distribution, 1167 articles were from the Eastern Hemisphere, with 326 (27.9 %) included; 255 were from the Western Hemisphere, and 95 (37.3 %) were included. Regionally, 179 articles (42.5 %) from Europe were included, 140 (33.3 %) from the Western Pacific, 95 (22.6 %) from the Americas, 6 (1.4 %) from the Eastern Mediterranean, and 1 (0.2 %) from Southeast Asia. China, the United States, and Germany were the top publishing countries, with consistent growth in countries like China, South Korea, Spain, Brazil, Turkey, and Iran. Noteworthy researchers such as Cesar Fernandez-de-las-Penas, Zhi-shun LIU, Jing-wen YANG, Cun-zhi LIU, Li-xing LAO, Stefan N Willich, and Benno Brinkhaus have collaborated on research in areas such as pain management, cognitive impairments, insomnia, digestive system diseases, and urinary system diseases. There has been a particular increase in research focus on neck pain and myofascial trigger points.
Conclusion
Despite the growth in acupuncture RCTs, their impact on revising medical guidelines remains disproportionate. The skewed geographic distribution underscores the urgent need for more comprehensive, regionally-targeted trials to foster globally applicable outcomes.
目的评价针刺随机对照试验(RCTs)的现状、对指南的影响及未来发展趋势,为今后的研究方向提供参考。方法在Web of Science核心馆藏中检索与针灸相关的随机对照试验文献,确认纳入b谷歌Scholar指南。分析研究特点,预测未来研究方向。该分析涵盖了1422篇文章,反映了出版物从1993年至2002年的77篇文章大幅增加到2013年至2022年的960篇文章。西太平洋地区以622篇(43.7%)的论文发表数量领先,其次是欧洲(466篇,32.8%)、美洲(250篇,17.6%)、东地中海(62篇,4.4%)和东南亚(22篇,1.5%),非洲显示出研究空白。遗憾的是,只有29.6%(421篇)文章被纳入指南。研究成果纳入指南率低和研究领域分布不均的问题尤为突出。1993 - 2002年共有77条,其中51条(66.2%)被纳入指南;2003 - 2012年共收录文献385篇,其中202篇(52.5%);2013 - 2022年共960篇文章,其中只有168篇(17.5%)被收录,收录率呈逐年下降趋势。地理分布方面,来自东半球的文献1167篇,其中326篇(27.9%);255例来自西半球,其中95例(37.3%)。从地区上看,179篇(42.5%)来自欧洲,140篇(33.3%)来自西太平洋,95篇(22.6%)来自美洲,6篇(1.4%)来自东地中海,1篇(0.2%)来自东南亚。中国、美国和德国是发行量最大的国家,中国、韩国、西班牙、巴西、土耳其和伊朗等国家的发行量也在持续增长。Cesar Fernandez-de-las-Penas、LIU zhishun、YANG Jing-wen、LIU存之、LAO Li-xing、Stefan N Willich、Benno Brinkhaus等知名研究人员在疼痛管理、认知障碍、失眠、消化系统疾病和泌尿系统疾病等领域进行了合作研究。特别是对颈部疼痛和肌筋膜触发点的研究增加了。结论尽管针灸随机对照试验的数量有所增加,但其对修订医疗指南的影响仍然不成比例。这种倾斜的地理分布突出表明,迫切需要开展更全面、更有针对性的试验,以促进全球适用的结果。
{"title":"Global acupuncture randomized controlled trials: Evaluating status, guideline impact, and future research trends","authors":"Gao-feng LIU (刘高峰) , Xiao-li HUANG (黄小力) , Wei-xing ZHONG (钟伟兴) , Yin XIE (解寅) , Si-yuan XIE (谢思远) , Yuan-xun LIN (林源洵) , Yun-ao-long ZHANG (张沄奡龙) , Hong-wen LIU (刘洪文) , Qing-guang QIN (秦庆广) , Yi-kai LI (李义凯)","doi":"10.1016/j.wjam.2025.09.004","DOIUrl":"10.1016/j.wjam.2025.09.004","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aims to evaluate the current state of acupuncture randomized controlled trials (RCTs), their impact on guidelines, and future development trends, providing a reference for future research directions.</div></div><div><h3>Methods</h3><div>Search for acupuncture-related RCT articles in the Web of Science Core Collection and confirm their guideline inclusion on Google Scholar. Analyze study characteristics to predict future research directions.</div></div><div><h3>Results</h3><div>The analysis covered 1422 articles, reflecting a substantial rise in publications from 77 articles between 1993 and 2002 to 960 articles between 2013 and 2022. The Western Pacific region led in publication numbers with 622 articles (43.7 %), followed by Europe (466 articles; 32.8 %), Americas (250 articles; 17.6 %), Eastern Mediterranean (62 articles; 4.4 %), and Southeast Asia (22 articles; 1.5 %), with Africa showing a research void. Regrettably, only 29.6 % (421 articles) were incorporated into guidelines. The low rate of inclusion of research results in guidelines and the uneven distribution of research fields are particularly prominent. From 1993 to 2002, there were 77 articles, among which 51 (66.2 %) were included in the guidelines; from 2003 to 2012, there were 385 articles, with 202 (52.5 %) included; from 2013 to 2022, there were 960 articles, and only 168 (17.5 %) were included, showing a decreasing trend in the inclusion rate year by year. Regarding geographical distribution, 1167 articles were from the Eastern Hemisphere, with 326 (27.9 %) included; 255 were from the Western Hemisphere, and 95 (37.3 %) were included. Regionally, 179 articles (42.5 %) from Europe were included, 140 (33.3 %) from the Western Pacific, 95 (22.6 %) from the Americas, 6 (1.4 %) from the Eastern Mediterranean, and 1 (0.2 %) from Southeast Asia. China, the United States, and Germany were the top publishing countries, with consistent growth in countries like China, South Korea, Spain, Brazil, Turkey, and Iran. Noteworthy researchers such as Cesar Fernandez-de-las-Penas, Zhi-shun LIU, Jing-wen YANG, Cun-zhi LIU, Li-xing LAO, Stefan N Willich, and Benno Brinkhaus have collaborated on research in areas such as pain management, cognitive impairments, insomnia, digestive system diseases, and urinary system diseases. There has been a particular increase in research focus on neck pain and myofascial trigger points.</div></div><div><h3>Conclusion</h3><div>Despite the growth in acupuncture RCTs, their impact on revising medical guidelines remains disproportionate. The skewed geographic distribution underscores the urgent need for more comprehensive, regionally-targeted trials to foster globally applicable outcomes.</div></div>","PeriodicalId":44648,"journal":{"name":"World Journal of Acupuncture-Moxibustion","volume":"35 4","pages":"Pages 331-340"},"PeriodicalIF":1.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145499879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01DOI: 10.1016/j.wjam.2025.09.003
Wen-qing HU (胡文清) , Jian-fei SHI (石健菲) , Yuan LU (陆嫄) , Huan-gan WU (吴焕淦) , Guo-na LI (李国娜) , Xiao-ling YIN (殷晓聆) , Dan-li JIAO (焦丹丽) , Jing LI (李璟) , Ling-xiang WU (吴凌翔) , Chen ZHAO (赵琛)
Objective
To observe the effects of moxibustion on the hematopoietic function in mice with aplastic anemia (AA) induced by bone marrow (BM) suppression, and to investigate the intervention effects of moxibustion on AA from the perspective of intestinal bacteria.
Methods
A total of 24 C57BL/6 J male mice were randomly and evenly divided into control, model and moxibustion groups. The myelosuppression-induced AA model was established by cyclophosphamide (CTX) and cyclosporine (Cs) intraperitoneal injection. Mice in the moxibustion group were intervened in mild moxibustion at unilateral “Zusanli(ST36)” acupoint for 15 min per day, and the sides were switched the next day. The intervention of mild moxibustion lasted 60 days consecutively. The red blood cell (RBC), white blood cell (WBC), platelet (PLT) counts and haemoglobin (Hb) concentration levels of mice in each group were detected by peripheral blood cells count staining, and the BM hematopoietic cells and hematopoietic structures were observed by BM smear Wright-Giemsa staining and HE staining. 16SrDNA sequencing was used to analyze the gut bacterial species abundance and diversity in mice from each group.
Results
After all the intervention, compared to the control group, the model group had lower levels of RBC, WBC, PLT counts and Hb concentration in peripheral blood (P < 0.05) and fewer hematopoietic cells and hematopoietic structures; compared to the model group, moxibustion group had higher levels of RBC, WBC, PLT counts and Hb concentration in peripheral blood (P < 0.05), and more BM hematopoietic cells and hematopoietic structures. Gut flora showed that moxibustion increased the species richness and diversity of intestinal bacteria in mice; compared with the control group, the relative abundance of Faecalibaculum and Anaeroplasmataceae in the model group was higher (P < 0.05); whereas, the relative abundance of Faecalibaculum and Anaeroplasmataceae in the moxibustion group was lower (P < 0.05) when compared with the model group. In addition, Faecalibaculum was significantly correlated with RBC, WBC, PLT count and Hb concentration (P < 0.05).
Conclusion
Moxibustion can improved BM histology, restored hematopoietic cells function, and increased peripheral blood cells count and Hb concentration in AA mice. The mechanism may be related to the fact that moxibustion regulates the abundance of specific intestinal bacteria to maintain the stability of the flora structure.
{"title":"Moxibustion modulates gut microbiota and improves bone marrow hematopoiesis in mice with myelosuppression-induced aplastic anemia","authors":"Wen-qing HU (胡文清) , Jian-fei SHI (石健菲) , Yuan LU (陆嫄) , Huan-gan WU (吴焕淦) , Guo-na LI (李国娜) , Xiao-ling YIN (殷晓聆) , Dan-li JIAO (焦丹丽) , Jing LI (李璟) , Ling-xiang WU (吴凌翔) , Chen ZHAO (赵琛)","doi":"10.1016/j.wjam.2025.09.003","DOIUrl":"10.1016/j.wjam.2025.09.003","url":null,"abstract":"<div><h3>Objective</h3><div>To observe the effects of moxibustion on the hematopoietic function in mice with aplastic anemia (AA) induced by bone marrow (BM) suppression, and to investigate the intervention effects of moxibustion on AA from the perspective of intestinal bacteria.</div></div><div><h3>Methods</h3><div>A total of 24 C57BL/6 J male mice were randomly and evenly divided into control, model and moxibustion groups. The myelosuppression-induced AA model was established by cyclophosphamide (CTX) and cyclosporine (Cs) intraperitoneal injection. Mice in the moxibustion group were intervened in mild moxibustion at unilateral “Zusanli(ST36)” acupoint for 15 min per day, and the sides were switched the next day. The intervention of mild moxibustion lasted 60 days consecutively. The red blood cell (RBC), white blood cell (WBC), platelet (PLT) counts and haemoglobin (Hb) concentration levels of mice in each group were detected by peripheral blood cells count staining, and the BM hematopoietic cells and hematopoietic structures were observed by BM smear Wright-Giemsa staining and HE staining. 16SrDNA sequencing was used to analyze the gut bacterial species abundance and diversity in mice from each group.</div></div><div><h3>Results</h3><div>After all the intervention, compared to the control group, the model group had lower levels of RBC, WBC, PLT counts and Hb concentration in peripheral blood (<em>P</em> < 0.05) and fewer hematopoietic cells and hematopoietic structures; compared to the model group, moxibustion group had higher levels of RBC, WBC, PLT counts and Hb concentration in peripheral blood (<em>P</em> < 0.05), and more BM hematopoietic cells and hematopoietic structures. Gut flora showed that moxibustion increased the species richness and diversity of intestinal bacteria in mice; compared with the control group, the relative abundance of <em>Faecalibaculum</em> and <em>Anaeroplasmataceae</em> in the model group was higher (<em>P</em> < 0.05); whereas, the relative abundance of <em>Faecalibaculum</em> and <em>Anaeroplasmataceae</em> in the moxibustion group was lower (<em>P</em> < 0.05) when compared with the model group. In addition, <em>Faecalibaculum</em> was significantly correlated with RBC, WBC, PLT count and Hb concentration (<em>P</em> < 0.05).</div></div><div><h3>Conclusion</h3><div>Moxibustion can improved BM histology, restored hematopoietic cells function, and increased peripheral blood cells count and Hb concentration in AA mice. The mechanism may be related to the fact that moxibustion regulates the abundance of specific intestinal bacteria to maintain the stability of the flora structure.</div></div>","PeriodicalId":44648,"journal":{"name":"World Journal of Acupuncture-Moxibustion","volume":"35 4","pages":"Pages 357-366"},"PeriodicalIF":1.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145499882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01DOI: 10.1016/j.wjam.2025.08.003
Yin-long LI (李印泷), Shu-dong LI (李述东), Yuan WU (吴远), Wen-jun YI (易文军), Qiu-fang ZUO (左秋芳), Xiao-chun YU (喻晓春)
China Association of Acupuncture and Moxibustion (CAAM) is the largest acupuncture-moxibustion individual member science and technology group in the world, and has become an important academic organization leading the development of international acupuncture-moxibustion discipline over the past 40 years. This paper systematically reviews the work of CAAM in international communication, policy making, basic research, scientific knowledge popularization and integrated development of industry, education and research. (1) Enhancing the world recognition of acupuncture and moxibustion by means of innovation. (2) Building a highland for the domestic development of acupuncture and moxibustion with comprehensive strategies. (3) Consolidating the foundation for the development of acupuncture-moxibustion discipline. (4) Driving scientific knowledge popularization in a variety of forms and contents. (5) Coordinating resources to promote integrated development of industry, education and research. Guided by inheriting the essence and maintaining the right while innovating, CAAM has played an important role in promoting the modernization and internationalization of acupuncture-moxibustion discipline, and contributed to the construction of Healthy China initiative with our wisdom. Focusing on domestic and international perspectives, CAAM strives to promote the development of acupuncture-moxibustion discipline and industry, and contribute greatly to health for all with acupuncture and moxibustion. CAAM will continue to deepen international cooperation, strengthen talent cultivation, promote the commercialization of scientific and research findings, advance the standardization of acupuncture-moxibustion equipment and techniques and build a unified standard system of acupuncture and moxibustion worldwide.
{"title":"China Association of Acupuncture and Moxibustion leading the development of acupuncture-moxibustion discipline: Achievement and practice","authors":"Yin-long LI (李印泷), Shu-dong LI (李述东), Yuan WU (吴远), Wen-jun YI (易文军), Qiu-fang ZUO (左秋芳), Xiao-chun YU (喻晓春)","doi":"10.1016/j.wjam.2025.08.003","DOIUrl":"10.1016/j.wjam.2025.08.003","url":null,"abstract":"<div><div>China Association of Acupuncture and Moxibustion (CAAM) is the largest acupuncture-moxibustion individual member science and technology group in the world, and has become an important academic organization leading the development of international acupuncture-moxibustion discipline over the past 40 years. This paper systematically reviews the work of CAAM in international communication, policy making, basic research, scientific knowledge popularization and integrated development of industry, education and research. (1) Enhancing the world recognition of acupuncture and moxibustion by means of innovation. (2) Building a highland for the domestic development of acupuncture and moxibustion with comprehensive strategies. (3) Consolidating the foundation for the development of acupuncture-moxibustion discipline. (4) Driving scientific knowledge popularization in a variety of forms and contents. (5) Coordinating resources to promote integrated development of industry, education and research. Guided by inheriting the essence and maintaining the right while innovating, CAAM has played an important role in promoting the modernization and internationalization of acupuncture-moxibustion discipline, and contributed to the construction of Healthy China initiative with our wisdom. Focusing on domestic and international perspectives, CAAM strives to promote the development of acupuncture-moxibustion discipline and industry, and contribute greatly to health for all with acupuncture and moxibustion. CAAM will continue to deepen international cooperation, strengthen talent cultivation, promote the commercialization of scientific and research findings, advance the standardization of acupuncture-moxibustion equipment and techniques and build a unified standard system of acupuncture and moxibustion worldwide.</div></div>","PeriodicalId":44648,"journal":{"name":"World Journal of Acupuncture-Moxibustion","volume":"35 4","pages":"Pages 393-397"},"PeriodicalIF":1.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145500437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01DOI: 10.1016/j.wjam.2025.09.008
Huan-fang XU (许焕芳) , Peng-fei DU (杜鹏飞) , Dong-sheng XU (徐东升), Jing-jing Cui (崔晶晶), Yi-gong FANG (房繄恭), Jia WANG (王佳), Li YANG (杨莉)
Objective
To investigate the distribution characteristics of sensory, sympathetic, and motor neurons associated with the "Shenshu (BL 23)" and "Guanyuan (CV 4)" acupoints and the ovary, and to elucidate the neural anatomical connections between these acupoints and the ovary.
Methods
In this study, dual fluorescent neural tracing was utilized, with twelve female Sprague-Dawley rats being randomly allocated into two groups (n = 6 per group) for the purpose of administering tracer injections at distinct anatomical sites: the "BL 23"-ovary group received injections of Alexa Fluor 488-conjugated cholera toxin subunit B (AF488-CTB) at the left "BL 23" and Fluoro-Gold (FG) in the left ovary; the "CV 4"-ovary group received AF488-CTB at “CV 4” and FG in the left ovary. Three days post-injection, the distribution of AF488-CTB and FG-labeled neural components was observed in the dorsal root ganglia (DRGs), sympathetic chain, and spinal cord tissues.
Results
① Sensory neurons labeled with AF488-CTB associated with "BL 23" were primarily distributed in the thoracic (T) 10 to lumbar (L) 2 DRGs, concentrated in T12-T13; postganglionic sympathetic neurons were mainly located in the thoracolumbar sympathetic chain; motor neurons were predominantly found in the anterior horn of the T11-L1 spinal cord segments. ② Sensory neurons labeled with AF488-CTB associated with "CV 4" were primarily located in T10-L3 DRGs, concentrated in T13-L2 DRGs; postganglionic sympathetic neurons were mainly distributed in the lumbar sympathetic chain; motor neurons were primarily found in the anterior horn of T11-L2 spinal cord segments. ③ FG-labeled sensory neurons associated with the ovary were mainly distributed in the T9-L3 DRGs, concentrated in the T12-L2 DRGs; postganglionic sympathetic neurons were primarily located in the lumbar sympathetic chain. ④ Double-labeled (AF488-CTB and FG) sensory neurons associated with the "BL 23" and ovary were mainly distributed in the T12-T13 DRGs, with double-labeled postganglionic sympathetic neurons primarily in the lumbar sympathetic chain; double-labeled sensory neurons associated with the "CV 4" and ovary were mainly distributed in the T13-L1 DRGs, with double-labeled postganglionic sympathetic neurons primarily in the lumbar sympathetic chain. No double-labeled motor neurons were observed for either acupoint with the ovary.
Conclusion
"BL 23" and "CV 4" and the ovary in rats exhibit segmental connections in sensory and sympathetic innervation, which may serve as the neural anatomical pathway and basis for acupuncture at these acupoints to regulate ovarian function.
{"title":"Neural anatomical connections between \"Shenshu(BL 23)\" \"Guanyuan(CV 4)\" and the ovary in rats","authors":"Huan-fang XU (许焕芳) , Peng-fei DU (杜鹏飞) , Dong-sheng XU (徐东升), Jing-jing Cui (崔晶晶), Yi-gong FANG (房繄恭), Jia WANG (王佳), Li YANG (杨莉)","doi":"10.1016/j.wjam.2025.09.008","DOIUrl":"10.1016/j.wjam.2025.09.008","url":null,"abstract":"<div><h3>Objective</h3><div>To investigate the distribution characteristics of sensory, sympathetic, and motor neurons associated with the \"Shenshu (BL 23)\" and \"Guanyuan (CV 4)\" acupoints and the ovary, and to elucidate the neural anatomical connections between these acupoints and the ovary.</div></div><div><h3>Methods</h3><div>In this study, dual fluorescent neural tracing was utilized, with twelve female Sprague-Dawley rats being randomly allocated into two groups (<em>n</em> = 6 per group) for the purpose of administering tracer injections at distinct anatomical sites: the \"BL 23\"-ovary group received injections of Alexa Fluor 488-conjugated cholera toxin subunit B (AF488-CTB) at the left \"BL 23\" and Fluoro-Gold (FG) in the left ovary; the \"CV 4\"-ovary group received AF488-CTB at “CV 4” and FG in the left ovary. Three days post-injection, the distribution of AF488-CTB and FG-labeled neural components was observed in the dorsal root ganglia (DRGs), sympathetic chain, and spinal cord tissues.</div></div><div><h3>Results</h3><div>① Sensory neurons labeled with AF488-CTB associated with \"BL 23\" were primarily distributed in the thoracic (T) 10 to lumbar (L) 2 DRGs, concentrated in T12-T13; postganglionic sympathetic neurons were mainly located in the thoracolumbar sympathetic chain; motor neurons were predominantly found in the anterior horn of the T11-L1 spinal cord segments. ② Sensory neurons labeled with AF488-CTB associated with \"CV 4\" were primarily located in T10-L3 DRGs, concentrated in T13-L2 DRGs; postganglionic sympathetic neurons were mainly distributed in the lumbar sympathetic chain; motor neurons were primarily found in the anterior horn of T11-L2 spinal cord segments. ③ FG-labeled sensory neurons associated with the ovary were mainly distributed in the T9-L3 DRGs, concentrated in the T12-L2 DRGs; postganglionic sympathetic neurons were primarily located in the lumbar sympathetic chain. ④ Double-labeled (AF488-CTB and FG) sensory neurons associated with the \"BL 23\" and ovary were mainly distributed in the T12-T13 DRGs, with double-labeled postganglionic sympathetic neurons primarily in the lumbar sympathetic chain; double-labeled sensory neurons associated with the \"CV 4\" and ovary were mainly distributed in the T13-L1 DRGs, with double-labeled postganglionic sympathetic neurons primarily in the lumbar sympathetic chain. No double-labeled motor neurons were observed for either acupoint with the ovary.</div></div><div><h3>Conclusion</h3><div>\"BL 23\" and \"CV 4\" and the ovary in rats exhibit segmental connections in sensory and sympathetic innervation, which may serve as the neural anatomical pathway and basis for acupuncture at these acupoints to regulate ovarian function.</div></div>","PeriodicalId":44648,"journal":{"name":"World Journal of Acupuncture-Moxibustion","volume":"35 4","pages":"Pages 341-348"},"PeriodicalIF":1.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145499880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01DOI: 10.1016/j.wjam.2025.09.009
Wen-bin NIE (聂文彬) , Qi FAN (范琦) , Yi-xuan FENG (丰逸轩) , Yu-xiu SUN (孙玉秀) , Shi-xi HUANG (黄石玺) , Yong-ming YE (叶永铭) , Ming-juan HAN (韩明娟) , Wen-jing BAI (白文静) , Hong ZHAO (赵宏)
Objective
Although there is evidence to support the therapeutic effect of acupuncture on allergic rhinitis (AR), it is not clear whether acupuncture can achieve an efficacy comparable to that of pharmacological therapy. This multicenter, non-inferiority, single-blinded randomized controlled trial aimed to compare the differences in efficacy between warm needling (WN) therapy and loratadine (LO) in improving AR symptoms and quality of life.
Methods
A total of 98 patients with persistent AR (PAR) were randomly divided into two groups in a 1:1 ratio: treatment group receiving WN therapy at Dazhui (GV14) and normal acupuncture at other acupoints for 12 sessions in 4 weeks and control group receiving LO at a dosage of 10 mg/day for oral administration. The study duration was 28 weeks (4-week treatment period with a 24-week follow-up). The primary outcome was the mean change in the Total Nasal Symptom Score (TNSS) from baseline to week 28, and the secondary outcomes included the Total Non-Nasal Symptom Score (TNNSS) and the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) score. Statistical analyses were conducted using SPSS22.0. Both intention-to-treat and treatment compliance analyses were performed to analyze all outcomes.
Results
After intervention, TNSS scores improved from baseline to week 28 by 5.18 (95 % confidence interval [CI]: 3.91, 6.45; P < 0.001) in the WN group and 4.59 (95 % CI 3.28, 5.89; P < 0.001) in the LO group, but the changes did not differ between the groups (P = 0.515). The margin by 95 % CI (−1.20, 2.38) was not reached, indicating non-inferiority. WN therapy resulted in clinical improvements in TNNSS, with a significant difference compared with LO treatment (f = 5.466, P = 0.021). WN therapy also resulted in clinical improvements in RQLQ scores, with a significant difference compared with LO (f = 9.222, P = 0.003).
Conclusions
WN therapy demonstrated comparable efficacy to oral LO in improving nasal symptoms of PAR. However, it showed superior effects in alleviating concomitant nasal symptoms and enhancing patients’ quality of life.
目的虽然有证据支持针灸治疗变应性鼻炎(AR)的疗效,但目前尚不清楚针灸是否能达到与药物治疗相当的疗效。这项多中心、非劣效性、单盲随机对照试验旨在比较温针(WN)疗法和氯雷他定(LO)在改善AR症状和生活质量方面的疗效差异。方法将98例持续性AR (PAR)患者按1:1的比例随机分为两组:治疗组在大足穴(GV14)加其他穴位正常针刺,疗程12次,共4周;对照组口服LO,剂量为10 mg/d。研究时间为28周(治疗期4周,随访24周)。主要结局是总鼻症状评分(TNSS)从基线到第28周的平均变化,次要结局包括总非鼻症状评分(TNNSS)和鼻结膜炎生活质量问卷(RQLQ)评分。采用SPSS22.0进行统计分析。对所有结果进行意向治疗和治疗依从性分析。结果干预后,从基线到第28周,WN组的TNSS评分提高了5.18分(95%可信区间[CI]: 3.91, 6.45; P < 0.001), LO组的TNSS评分提高了4.59分(95% CI: 3.28, 5.89; P < 0.001),但两组之间的变化没有差异(P = 0.515)。未达到95% CI(- 1.20, 2.38),表明非劣效性。WN治疗可改善TNNSS的临床情况,与LO治疗相比差异有统计学意义(f = 5.466, P = 0.021)。治疗组RQLQ评分也有临床改善,与对照组相比差异有统计学意义(f = 9.222, P = 0.003)。结论swn治疗在改善PAR鼻部症状方面的疗效与口服LO相当,但在缓解伴有鼻部症状和提高患者生活质量方面效果更佳。临床试验注册:ClinicalTrials.gov标识符NCT02339714。
{"title":"Efficacy of warm needling in patients with persistent allergic rhinitis: A multicenter randomized controlled trial","authors":"Wen-bin NIE (聂文彬) , Qi FAN (范琦) , Yi-xuan FENG (丰逸轩) , Yu-xiu SUN (孙玉秀) , Shi-xi HUANG (黄石玺) , Yong-ming YE (叶永铭) , Ming-juan HAN (韩明娟) , Wen-jing BAI (白文静) , Hong ZHAO (赵宏)","doi":"10.1016/j.wjam.2025.09.009","DOIUrl":"10.1016/j.wjam.2025.09.009","url":null,"abstract":"<div><h3>Objective</h3><div>Although there is evidence to support the therapeutic effect of acupuncture on allergic rhinitis (AR), it is not clear whether acupuncture can achieve an efficacy comparable to that of pharmacological therapy. This multicenter, non-inferiority, single-blinded randomized controlled trial aimed to compare the differences in efficacy between warm needling (WN) therapy and loratadine (LO) in improving AR symptoms and quality of life.</div></div><div><h3>Methods</h3><div>A total of 98 patients with persistent AR (PAR) were randomly divided into two groups in a 1:1 ratio: treatment group receiving WN therapy at Dazhui (GV14) and normal acupuncture at other acupoints for 12 sessions in 4 weeks and control group receiving LO at a dosage of 10 mg/day for oral administration. The study duration was 28 weeks (4-week treatment period with a 24-week follow-up). The primary outcome was the mean change in the Total Nasal Symptom Score (TNSS) from baseline to week 28, and the secondary outcomes included the Total Non-Nasal Symptom Score (TNNSS) and the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) score. Statistical analyses were conducted using SPSS22.0. Both intention-to-treat and treatment compliance analyses were performed to analyze all outcomes.</div></div><div><h3>Results</h3><div>After intervention, TNSS scores improved from baseline to week 28 by 5.18 (95 % confidence interval [CI]: 3.91, 6.45; <em>P</em> < 0.001) in the WN group and 4.59 (95 % CI 3.28, 5.89; <em>P</em> < 0.001) in the LO group, but the changes did not differ between the groups (<em>P</em> = 0.515). The margin by 95 % CI (−1.20, 2.38) was not reached, indicating non-inferiority. WN therapy resulted in clinical improvements in TNNSS, with a significant difference compared with LO treatment (<em>f</em> = 5.466, <em>P</em> = 0.021). WN therapy also resulted in clinical improvements in RQLQ scores, with a significant difference compared with LO (<em>f</em> = 9.222, <em>P</em> = 0.003).</div></div><div><h3>Conclusions</h3><div>WN therapy demonstrated comparable efficacy to oral LO in improving nasal symptoms of PAR. However, it showed superior effects in alleviating concomitant nasal symptoms and enhancing patients’ quality of life.</div><div>Clinical Trial Registration: <span><span>ClinicalTrials.gov</span><svg><path></path></svg></span> Identifier NCT02339714.</div></div>","PeriodicalId":44648,"journal":{"name":"World Journal of Acupuncture-Moxibustion","volume":"35 4","pages":"Pages 349-356"},"PeriodicalIF":1.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145499881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01DOI: 10.1016/j.wjam.2025.09.007
Xiao-yan LYU (吕笑颜) , Xin-ru YUAN (袁馨如) , Zi-yang FAN (樊紫阳) , Jia-ni MA (马佳妮) , Chang-qi LI (李昌奇) , Xin-yang LI (李昕洋) , Hui ZHANG (张慧) , Li-yuan FU (傅丽媛) , Bin-xu SUN (孙彬栩) , Dan LI (李丹) , Xiao-hua WEN (温小华) , Tian-yi ZHAO (赵天易) , Mei-dan ZHAO (赵美丹) , Yi-nan GONG (公一囡) , Bin WANG (王斌) , Ao-xiang CHEN (陈翱翔) , Yi GUO (郭义) , Shi-yan YAN (闫世艳) , Bo CHEN (陈波)
Objective
In this study, we evaluated the methodological quality of systematic reviews on acupuncture and moxibustion for the prevention and management of cancer-related conditions, aiming to provide evidence-based support and establish levels of evidence for clinical application.
Method
A comprehensive search was conducted to identify systematic reviews on acupuncture and moxibustion for the prevention and management of cancer-related conditions, covering databases including PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure, Chinese Biomedical Databases, China Science and Technology Journal Database, and Wanfang Data, from their inception to August 1, 2024. The methodological quality of the included systematic reviews was assessed by using AMSTAR 2, and bubble plots were employed to visualize the evidence.
Results
Overall, 137 systematic reviews were included, with China being the most prolific country, with 117 reviews. These reviews addressed 21 cancer-related conditions, with the three most frequently studied being cancer-related fatigue (25 reviews), nausea and vomiting (20 reviews), and cancer pain (19 reviews). The three most commonly used acupuncture modalities were manual acupuncture (81 reviews), electroacupuncture (55 reviews), and moxibustion (39 reviews). Quality assessment revealed that one systematic review was rated as ``high quality,” eight as ``low quality,” and 128 as ``critically low quality,” primarily due to the absence of protocol registration and lists of excluded studies.
Conclusion
Acupuncture and moxibustion have shown potential efficacy in alleviating cancer-related conditions and treatment-related adverse effects, and their clinical use has been widely reported. However, the overall methodological quality of the included systematic reviews was low, limiting the reliability and the strength of the evidence. Future high-quality studies are needed to improve the quality of evidence and support the standardized application and broader promotion of acupuncture and moxibustion clinical practice.
目的评价针灸预防和治疗癌症相关疾病系统评价的方法学质量,旨在为临床应用提供循证支持和建立证据水平。方法综合检索PubMed、Embase、Cochrane图书馆、Web of Science、中国国家知识基础设施、中国生物医学数据库、中国科技期刊数据库、万方数据等数据库自建库至2024年8月1日期间关于针灸预防和管理癌症相关疾病的系统综述。采用AMSTAR 2对纳入的系统评价的方法学质量进行评估,并采用气泡图将证据可视化。结果共纳入137篇系统综述,其中中国是最多的国家,有117篇综述。这些综述涉及21种癌症相关疾病,其中最常被研究的三种是癌症相关疲劳(25篇综述)、恶心和呕吐(20篇综述)和癌症疼痛(19篇综述)。三种最常用的针灸方式是手动针灸(81篇综述)、电针(55篇综述)和艾灸(39篇综述)。质量评估显示,1项系统评价被评为“高质量”,8项被评为“低质量”,128项被评为“严重低质量”,主要原因是缺乏方案注册和排除研究清单。结论针灸在缓解肿瘤相关疾病和治疗相关不良反应方面具有潜在疗效,其临床应用已被广泛报道。然而,纳入的系统评价的整体方法学质量较低,限制了证据的可靠性和强度。今后需要开展高质量的研究,以提高证据质量,支持针灸临床实践的规范化应用和更广泛的推广。
{"title":"Evidence map of systematic reviews on acupuncture and moxibustion for prevention and management of cancer-related conditions","authors":"Xiao-yan LYU (吕笑颜) , Xin-ru YUAN (袁馨如) , Zi-yang FAN (樊紫阳) , Jia-ni MA (马佳妮) , Chang-qi LI (李昌奇) , Xin-yang LI (李昕洋) , Hui ZHANG (张慧) , Li-yuan FU (傅丽媛) , Bin-xu SUN (孙彬栩) , Dan LI (李丹) , Xiao-hua WEN (温小华) , Tian-yi ZHAO (赵天易) , Mei-dan ZHAO (赵美丹) , Yi-nan GONG (公一囡) , Bin WANG (王斌) , Ao-xiang CHEN (陈翱翔) , Yi GUO (郭义) , Shi-yan YAN (闫世艳) , Bo CHEN (陈波)","doi":"10.1016/j.wjam.2025.09.007","DOIUrl":"10.1016/j.wjam.2025.09.007","url":null,"abstract":"<div><h3>Objective</h3><div>In this study, we evaluated the methodological quality of systematic reviews on acupuncture and moxibustion for the prevention and management of cancer-related conditions, aiming to provide evidence-based support and establish levels of evidence for clinical application.</div></div><div><h3>Method</h3><div>A comprehensive search was conducted to identify systematic reviews on acupuncture and moxibustion for the prevention and management of cancer-related conditions, covering databases including PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure, Chinese Biomedical Databases, China Science and Technology Journal Database, and Wanfang Data, from their inception to August 1, 2024. The methodological quality of the included systematic reviews was assessed by using AMSTAR 2, and bubble plots were employed to visualize the evidence.</div></div><div><h3>Results</h3><div>Overall, 137 systematic reviews were included, with China being the most prolific country, with 117 reviews. These reviews addressed 21 cancer-related conditions, with the three most frequently studied being cancer-related fatigue (25 reviews), nausea and vomiting (20 reviews), and cancer pain (19 reviews). The three most commonly used acupuncture modalities were manual acupuncture (81 reviews), electroacupuncture (55 reviews), and moxibustion (39 reviews). Quality assessment revealed that one systematic review was rated as ``high quality,” eight as ``low quality,” and 128 as ``critically low quality,” primarily due to the absence of protocol registration and lists of excluded studies.</div></div><div><h3>Conclusion</h3><div>Acupuncture and moxibustion have shown potential efficacy in alleviating cancer-related conditions and treatment-related adverse effects, and their clinical use has been widely reported. However, the overall methodological quality of the included systematic reviews was low, limiting the reliability and the strength of the evidence. Future high-quality studies are needed to improve the quality of evidence and support the standardized application and broader promotion of acupuncture and moxibustion clinical practice.</div></div>","PeriodicalId":44648,"journal":{"name":"World Journal of Acupuncture-Moxibustion","volume":"35 4","pages":"Pages 290-302"},"PeriodicalIF":1.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145500440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01DOI: 10.1016/j.wjam.2025.07.001
Xue-chao HUANG (黄学超) , Jing-xuan LIU (刘敬萱) , Tian-yu LI (李天玉) , Rui ZHANG (张锐) , Qian MO (默倩) , Guo-wu LEI (雷国伍) , Ran-ran LIU (刘冉冉) , Chun-sheng JIA (贾春生) , Li-Jia PAN (潘丽佳)
<div><h3>Objective</h3><div>To explore the mechanism of electroacupuncture (EA) on inhibiting tumor growth in breast cancer-bearing mice.</div></div><div><h3>Methods</h3><div>Thirty Bagg Albino (c) (BALB/c) mice were randomly divided into a sham-operation group, a tumor group, a chemotherapy group, and an acupuncture group, and an EA group, with six mice in each one. Except in the sham-operation group, 4T1 cells were injected into the fourth mammary fat pad on the right side of each mouse in the rest groups to develop breast-cancer bearing models. In the sham-operation group, the sham operation was underwent by injecting normal saline with the same volume as 4T1 cell suspension. After successful modeling, the intraperitoneal injection of doxorubicin solution was delivered in the chemotherapy group. In the acupuncture group, needles was inserted at “Zusanli” (ST36) and “Sanyinjiao” (SP6) perpendicularly, without manipulation, once daily and needles were retained for 15 min. In the EA group, on the basis of the operation as the acupuncture group, electric stimulation was attached to “ST36” (positive electrode) and “SP6” (negative electrode), once daily, 15 min each time. Starting on Day 1 of intervention, the changes of tumor volume was observed once every two days in each group photographed. The sample was collected on Day 21 of intervention. The tumors were photographed and weighed. Hematoxylin-eosin (HE) staining was used to observe the pathological changes of tumor tissue. Western blot, fluorescence quantitative polymerase chain reaction (FQ-PCR), and immunohistochemistry (IHC) were adopted to detect the protein expression, mRNA expression, and positive expression of CYLD, BCL-3, and P50 in tumor tissue, respectively.</div></div><div><h3>Results</h3><div>(1) The tumor volume in the tumor group, chemotherapy group, acupuncture group, and EA group was (815.67 ± 275.61) mm<sup>3</sup>, (197.50 ± 66.11) mm<sup>3</sup>, (412.62 ± 58.96) mm³, and (327.51 ± 125.46) mm<sup>3</sup>, respectively, and the tumor mass was (1.21 ± 0.39) g, (0.39 ± 0.05) g, (0.66 ± 0.06) g, and (0.55 ± 0.11) g on Day 21 of intervention, respectively. Compared with the tumor group, the tumor volume and mass were lower in the chemotherapy group, acupuncture group, and EA group (<em>P</em> < 0.05). (2) Respectively, in the tumor group, chemotherapy group, acupuncture group, and EA group, the mRNA expression of CYLD in tumor tissue was 1.01 ± 0.19, 2.90 ± 0.24, 2.55 ± 0.03, and 4.01 ± 0.32; the protein expression was 1.00 ± 0.00, 1.88 ± 0.16, 1.64 ± 0.11, and 2.30 ± 0.29; and the positive expression was 0.06 ± 0.01, 0.11 ± 0.01, 0.11 ± 0.004, and 0.14 ± 0.003. Compared with the tumor group, the mRNA expression, protein expression, and positive expression of CYLD were higher in the intervention groups (<em>P</em> < 0.05), and each expression in the EA group was higher in comparison with the chemotherapy and acupuncture groups (<em>P</em> < 0.05). (3) The mRNA expression
{"title":"Mechanisms of tumor growth inhibition by electroacupuncture in breast cancer-bearing mice","authors":"Xue-chao HUANG (黄学超) , Jing-xuan LIU (刘敬萱) , Tian-yu LI (李天玉) , Rui ZHANG (张锐) , Qian MO (默倩) , Guo-wu LEI (雷国伍) , Ran-ran LIU (刘冉冉) , Chun-sheng JIA (贾春生) , Li-Jia PAN (潘丽佳)","doi":"10.1016/j.wjam.2025.07.001","DOIUrl":"10.1016/j.wjam.2025.07.001","url":null,"abstract":"<div><h3>Objective</h3><div>To explore the mechanism of electroacupuncture (EA) on inhibiting tumor growth in breast cancer-bearing mice.</div></div><div><h3>Methods</h3><div>Thirty Bagg Albino (c) (BALB/c) mice were randomly divided into a sham-operation group, a tumor group, a chemotherapy group, and an acupuncture group, and an EA group, with six mice in each one. Except in the sham-operation group, 4T1 cells were injected into the fourth mammary fat pad on the right side of each mouse in the rest groups to develop breast-cancer bearing models. In the sham-operation group, the sham operation was underwent by injecting normal saline with the same volume as 4T1 cell suspension. After successful modeling, the intraperitoneal injection of doxorubicin solution was delivered in the chemotherapy group. In the acupuncture group, needles was inserted at “Zusanli” (ST36) and “Sanyinjiao” (SP6) perpendicularly, without manipulation, once daily and needles were retained for 15 min. In the EA group, on the basis of the operation as the acupuncture group, electric stimulation was attached to “ST36” (positive electrode) and “SP6” (negative electrode), once daily, 15 min each time. Starting on Day 1 of intervention, the changes of tumor volume was observed once every two days in each group photographed. The sample was collected on Day 21 of intervention. The tumors were photographed and weighed. Hematoxylin-eosin (HE) staining was used to observe the pathological changes of tumor tissue. Western blot, fluorescence quantitative polymerase chain reaction (FQ-PCR), and immunohistochemistry (IHC) were adopted to detect the protein expression, mRNA expression, and positive expression of CYLD, BCL-3, and P50 in tumor tissue, respectively.</div></div><div><h3>Results</h3><div>(1) The tumor volume in the tumor group, chemotherapy group, acupuncture group, and EA group was (815.67 ± 275.61) mm<sup>3</sup>, (197.50 ± 66.11) mm<sup>3</sup>, (412.62 ± 58.96) mm³, and (327.51 ± 125.46) mm<sup>3</sup>, respectively, and the tumor mass was (1.21 ± 0.39) g, (0.39 ± 0.05) g, (0.66 ± 0.06) g, and (0.55 ± 0.11) g on Day 21 of intervention, respectively. Compared with the tumor group, the tumor volume and mass were lower in the chemotherapy group, acupuncture group, and EA group (<em>P</em> < 0.05). (2) Respectively, in the tumor group, chemotherapy group, acupuncture group, and EA group, the mRNA expression of CYLD in tumor tissue was 1.01 ± 0.19, 2.90 ± 0.24, 2.55 ± 0.03, and 4.01 ± 0.32; the protein expression was 1.00 ± 0.00, 1.88 ± 0.16, 1.64 ± 0.11, and 2.30 ± 0.29; and the positive expression was 0.06 ± 0.01, 0.11 ± 0.01, 0.11 ± 0.004, and 0.14 ± 0.003. Compared with the tumor group, the mRNA expression, protein expression, and positive expression of CYLD were higher in the intervention groups (<em>P</em> < 0.05), and each expression in the EA group was higher in comparison with the chemotherapy and acupuncture groups (<em>P</em> < 0.05). (3) The mRNA expression ","PeriodicalId":44648,"journal":{"name":"World Journal of Acupuncture-Moxibustion","volume":"35 4","pages":"Pages 367-375"},"PeriodicalIF":1.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145499884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01DOI: 10.1016/j.wjam.2025.09.002
Quan MIAO (苗荃), Qiu-yi CHEN (陈秋怡), Sheng-xian LI (李晟贤), Wo-yu WANG (王握瑜), Li-min NIE (聂利敏), Shu-ting LI (郦淑婷), Ying LIN (林颖), Yu-han LIU (刘昱含), Lu LIU (刘璐), Bin LI (李彬)
Background
Temporomandibular disorders (TMD) are the leading cause of chronic orofacial pain, which significantly affects patients’ quality of life. However, the efficacy of acupuncture in the management of TMD remains unclear.
Objective
This systematic review aimed to conduct a PRISMA-compliant review to critically assess the therapeutic efficacy of acupuncture as an intervention for patients with TMD.
Methods
We searched nine electronic databases for randomized controlled trials on acupuncture for TMD published up to February 4, 2025. Eligible studies included adults diagnosed with TMD and compared acupuncture (manual, electroacupuncture, warm, auricular, thread-embedding, or laser) with conservative treatment (positive control) or sham acupuncture (negative control). Outcomes included pain intensity, mouth opening, pressure pain threshold, and adverse events. Risk of bias was assessed using ROB 2, and certainty of evidence was evaluated using GRADE. All outcome data were analyzed using RevMan 5.4 software. Low heterogeneity was defined as I² ≤ 50% and P ≥ 0.1, in which case a fixed-effects model was applied. High heterogeneity (I² > 50% or P < 0.1) prompted further analysis to identify its source. After excluding the influence of evident heterogeneity, a random-effects model was used for the meta-analysis.
Results
Of the 2664 screened records, 14 randomized controlled trials involving 476 participants met the inclusion criteria. Acupuncture significantly reduced pain intensity compared with that of negative controls (MD = −1.75, 95% confidence interval [CI] −2.47 to −1.03; P < 0.00001; I² = 60%) but showed no difference compared with that of positive controls (MD = −0.06, 95% CI −0.62 to 0.50; P = 0.83; I² = 0%). No significant differences were observed in pain-free jaw opening, whereas acupuncture improved maximum mouth opening relative to negative controls (MD = 1.80, 95% CI 1.62 to 1.97; P < 0.00001; I² = 0%). For pressure pain threshold, two small studies suggested greater increases with acupuncture. Safety data were limited, with only one trial reporting mild adverse events in the acupuncture group.
Conclusion
Based on limited evidence, acupuncture appears superior to negative controls in relieving pain associated with TMD but shows no significant advantage over positive controls. The certainty of the evidence for all outcomes, as assessed by GRADE, was low or very low. Therefore, these findings should be interpreted with caution. Future high-quality randomized controlled trials are warranted to further evaluate the role of acupuncture in the management of patients with TMD.
{"title":"Acupuncture for the treatment of temporomandibular disorders: A systematic review and meta-analysis","authors":"Quan MIAO (苗荃), Qiu-yi CHEN (陈秋怡), Sheng-xian LI (李晟贤), Wo-yu WANG (王握瑜), Li-min NIE (聂利敏), Shu-ting LI (郦淑婷), Ying LIN (林颖), Yu-han LIU (刘昱含), Lu LIU (刘璐), Bin LI (李彬)","doi":"10.1016/j.wjam.2025.09.002","DOIUrl":"10.1016/j.wjam.2025.09.002","url":null,"abstract":"<div><h3>Background</h3><div>Temporomandibular disorders (TMD) are the leading cause of chronic orofacial pain, which significantly affects patients’ quality of life. However, the efficacy of acupuncture in the management of TMD remains unclear.</div></div><div><h3>Objective</h3><div>This systematic review aimed to conduct a PRISMA-compliant review to critically assess the therapeutic efficacy of acupuncture as an intervention for patients with TMD.</div></div><div><h3>Methods</h3><div>We searched nine electronic databases for randomized controlled trials on acupuncture for TMD published up to February 4, 2025. Eligible studies included adults diagnosed with TMD and compared acupuncture (manual, electroacupuncture, warm, auricular, thread-embedding, or laser) with conservative treatment (positive control) or sham acupuncture (negative control). Outcomes included pain intensity, mouth opening, pressure pain threshold, and adverse events. Risk of bias was assessed using ROB 2, and certainty of evidence was evaluated using GRADE. All outcome data were analyzed using RevMan 5.4 software. Low heterogeneity was defined as <em>I</em>² ≤ 50% and <em>P</em> ≥ 0.1, in which case a fixed-effects model was applied. High heterogeneity (<em>I</em>² > 50% or <em>P</em> < 0.1) prompted further analysis to identify its source. After excluding the influence of evident heterogeneity, a random-effects model was used for the meta-analysis.</div></div><div><h3>Results</h3><div>Of the 2664 screened records, 14 randomized controlled trials involving 476 participants met the inclusion criteria. Acupuncture significantly reduced pain intensity compared with that of negative controls (MD = −1.75, 95% confidence interval [CI] −2.47 to −1.03; <em>P</em> < 0.00001; I² = 60%) but showed no difference compared with that of positive controls (MD = −0.06, 95% CI −0.62 to 0.50; <em>P</em> = 0.83; I² = 0%). No significant differences were observed in pain-free jaw opening, whereas acupuncture improved maximum mouth opening relative to negative controls (MD = 1.80, 95% CI 1.62 to 1.97; <em>P</em> < 0.00001; I² = 0%). For pressure pain threshold, two small studies suggested greater increases with acupuncture. Safety data were limited, with only one trial reporting mild adverse events in the acupuncture group.</div></div><div><h3>Conclusion</h3><div>Based on limited evidence, acupuncture appears superior to negative controls in relieving pain associated with TMD but shows no significant advantage over positive controls. The certainty of the evidence for all outcomes, as assessed by GRADE, was low or very low. Therefore, these findings should be interpreted with caution. Future high-quality randomized controlled trials are warranted to further evaluate the role of acupuncture in the management of patients with TMD.</div></div>","PeriodicalId":44648,"journal":{"name":"World Journal of Acupuncture-Moxibustion","volume":"35 4","pages":"Pages 320-330"},"PeriodicalIF":1.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145500443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01DOI: 10.1016/j.wjam.2025.09.005
Xiao-xuan GENG (耿晓萱), Sheng CHEN (陈晟), Wen-yi YANG (杨文夷), Mei-lun HUANG (黄美伦), Jia-le KANG (康家乐)
A 30-year-old female patient with Bartholin’s abscess was treated by acupuncture. Before visit, she had taken wuwei xiaodu yin for 4 consecutive days, but the symptoms were not alleviated markedly and pain was worsening. According to the conditions of tongue and pulse, and physical signs, the case was differentiated as pathogenic heat invading blood phase; and the injury of qi and yin by the herbal decoction the patient took before. In treatment with acupuncture, the treatment principle focused on benefiting qi, nourishing yin, expelling pus from the interior and draining toxin, and promoting the circulations of meridians to stop pain. He-sea points were selected to clear heat and resolve damp, and replenish the liver and kidney; and the acupoints of bladder meridian were combined under the guidance of “taiyang dominating the openings,” aiming at elevating qi and expelling toxin from the interior. Acupuncture was given once daily. After treated for 4 days, abscess was ruptured, pain disappeared, and no recurrence was presented and no sequelae happened during over 2 years of follow-up. This case shows that acupuncture is effective on Bartholin’s abscess. By reviewing this case, it is put forward that there may by the signs before the onset of Bartholin’s abscess, and the treatment should focus on opening a way for eliminating pathogens. Moreover, the clinical trial is required to verify acupuncture effect on this disease.
{"title":"Acupuncture treatment for Bartholin’s abscesst: A case report and literature review","authors":"Xiao-xuan GENG (耿晓萱), Sheng CHEN (陈晟), Wen-yi YANG (杨文夷), Mei-lun HUANG (黄美伦), Jia-le KANG (康家乐)","doi":"10.1016/j.wjam.2025.09.005","DOIUrl":"10.1016/j.wjam.2025.09.005","url":null,"abstract":"<div><div>A 30-year-old female patient with Bartholin’s abscess was treated by acupuncture. Before visit, she had taken <em>wuwei xiaodu yin</em> for 4 consecutive days, but the symptoms were not alleviated markedly and pain was worsening. According to the conditions of tongue and pulse, and physical signs, the case was differentiated as pathogenic heat invading blood phase; and the injury of <em>qi</em> and <em>yin</em> by the herbal decoction the patient took before. In treatment with acupuncture, the treatment principle focused on benefiting <em>qi</em>, nourishing <em>yin</em>, expelling pus from the interior and draining toxin, and promoting the circulations of meridians to stop pain. <em>He</em>-sea points were selected to clear heat and resolve damp, and replenish the liver and kidney; and the acupoints of bladder meridian were combined under the guidance of “<em>taiyang</em> dominating the openings,” aiming at elevating <em>qi</em> and expelling toxin from the interior. Acupuncture was given once daily. After treated for 4 days, abscess was ruptured, pain disappeared, and no recurrence was presented and no sequelae happened during over 2 years of follow-up. This case shows that acupuncture is effective on Bartholin’s abscess. By reviewing this case, it is put forward that there may by the signs before the onset of Bartholin’s abscess, and the treatment should focus on opening a way for eliminating pathogens. Moreover, the clinical trial is required to verify acupuncture effect on this disease.</div></div>","PeriodicalId":44648,"journal":{"name":"World Journal of Acupuncture-Moxibustion","volume":"35 4","pages":"Pages 384-387"},"PeriodicalIF":1.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145500434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01DOI: 10.1016/j.wjam.2025.08.002
Jin LU (卢进) , Jun-tao FENG (冯俊涛) , Lei-miao YIN (尹磊淼) , Yong-qing YANG (杨永清)
The development of adrenergic agonists (AAs) for asthma has provided important mechanistic insights into acupuncture-based target discovery and treatment strategies. This review describes the historical evolution of AA therapy, including the precise optimization of nonselective to β₂-selective agonists, improvement from short-acting to ultra-long-acting agents, shift from targeted monotherapy to combination regimens, and alterations in drug formulation. Additionally, this review summarizes recent advances in acupuncture treatment for asthma, including the development of novel targeted therapies, application of acupuncture-based combination regimens, and optimization of the mode of administration. Taken together, this article discusses key insights from research on AA that inform acupuncture approaches, with a focus on: (1) precision targeting: identifying acupuncture-specific targets to improve efficacy; (2) synergistic treatment: employing multi-target combination regimens to enhance therapeutic outcomes; (3) formulation innovation: advancing acupuncture delivery methods to improve patient compliance; and (4) evidence-based development: strengthening clinical research to generate high-quality evidence to inform the discovery of novel targets and treatment strategies for asthma.
{"title":"Adrenergic agonist therapy and emerging acupuncture targets in asthma: A review of mechanisms and therapeutic implications","authors":"Jin LU (卢进) , Jun-tao FENG (冯俊涛) , Lei-miao YIN (尹磊淼) , Yong-qing YANG (杨永清)","doi":"10.1016/j.wjam.2025.08.002","DOIUrl":"10.1016/j.wjam.2025.08.002","url":null,"abstract":"<div><div>The development of adrenergic agonists (AAs) for asthma has provided important mechanistic insights into acupuncture-based target discovery and treatment strategies. This review describes the historical evolution of AA therapy, including the precise optimization of nonselective to β₂-selective agonists, improvement from short-acting to ultra-long-acting agents, shift from targeted monotherapy to combination regimens, and alterations in drug formulation. Additionally, this review summarizes recent advances in acupuncture treatment for asthma, including the development of novel targeted therapies, application of acupuncture-based combination regimens, and optimization of the mode of administration. Taken together, this article discusses key insights from research on AA that inform acupuncture approaches, with a focus on: (1) precision targeting: identifying acupuncture-specific targets to improve efficacy; (2) synergistic treatment: employing multi-target combination regimens to enhance therapeutic outcomes; (3) formulation innovation: advancing acupuncture delivery methods to improve patient compliance; and (4) evidence-based development: strengthening clinical research to generate high-quality evidence to inform the discovery of novel targets and treatment strategies for asthma.</div></div>","PeriodicalId":44648,"journal":{"name":"World Journal of Acupuncture-Moxibustion","volume":"35 4","pages":"Pages 269-275"},"PeriodicalIF":1.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145500438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}